Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch Unique Embedded Aortic Triple-branch Arch Stent Graft System (GENIUS Study)

NCT06385379 is registered in ClinicalTrials.gov with Hangzhou Endonom Medtech Co., Ltd. as lead sponsor.

NCT NCT06385379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06385379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch Unique Embedded Aortic Triple-branch Arch Stent Graft System (GENIUS Study)
Lead sponsor
Hangzhou Endonom Medtech Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
June 30, 2024
Completion date
December 31, 2030
Enrollment
90 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

aortic arch aneurysm